Chronic Fatigue Syndrome More Common Than Previous Estimates

A CDC survey conducted in 2021–2022 estimated that 1.3% of U.S. adults—about 3.3 million people—reported currently having clinician-diagnosed myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This disabling multisystem condition is characterised by reduced activity, unrefreshing sleep and post-exertional malaise, where physical or mental effort causes a delayed and sometimes prolonged worsening of symptoms.

Chronic Fatigue Syndrome More Common Than Previous Estimates
Medically reviewed

Dr. Chrysoula I. Liakou MD, PhD Google Scholar LinkedIn

Internal Medicine Specialist
Cancer Immunology Researcher

What the 2021–2022 CDC Survey Reveals About Chronic Fatigue Syndrome (ME/CFS)

A recent study revealed that 1.3% of the United States population reported that their doctors diagnosed them with chronic fatigue syndrome.

The data indicates that symptoms of chronic fatigue are widespread throughout the U.S., impacting all segments of society.

People with chronic fatigue syndrome experience extreme tiredness lasting at least six months.

It is uncertain if the increasing number of individuals who have chronic fatigue syndrome is caused by long COVID cases, according to health authorities.

 

The Survey

The CDC recently conducted a survey to assess the number of Americans diagnosed with ME/CFS. The results of the survey indicated that a significant portion of the population had been diagnosed with ME/CFS.


The survey results showed that approximately 4.3 million people have been diagnosed with chronic fatigue syndrome by their doctor, which is equivalent to 1.3% of the total population of the country.


According to the CDC, the number of Americans living with chronic fatigue syndrome (CFS/ME) ranged from 836,000 to 2.5 million.


The CDC says about 90% of people with this condition haven't been diagnosed.


They also say that this illness costs the United States around $17 to $24 billion every year in medical bills and lost income.


CFS and M.E. are two names for the same sickness. "M.E." is more common in the United Kingdom, while "CFS" was first used in the U.S. Now, we usually call it "CFS/ME."


In 2021-2022, they asked 57,133 American adults if a doctor had told them they had CFS/ME.


CFS/ME is when you feel tired for at least six months.


More people are getting CFS/ME, and it might be because of long COVID, which is when the effects of COVID-19 last a long time.


A review in 2023 found that CFS/ME and chronic fatigue from long COVID are similar but not the same. An international survey found that 86.7% of people who didn't get better from long-term COVID-19 still had chronic fatigue.

 

What Is Chronic Fatigue Syndrome?


According to medical experts, the exact parameters of CFS/ME are unclear. There are multiple definitions for this condition, which can make it confusing.


This variability in definition is common when dealing with a medical condition called a "syndrome" rather than a disease. Diseases typically have a well-known, identifiable cause, while syndromes may have multiple, unknown, or poorly defined reasons. This lack of clarity in diagnosis can lead to differing opinions, with some believing the condition is under-diagnosed, while others may think it's over-diagnosed.


Who Is Affected By Chronic Fatigue?

The CDC survey provided the following key insights:

  • Women are more likely to report CFS/ME compared to men, with a prevalence of 1.7% in women and 0.9% in men.

  • CFS/ME cases were more commonly found in rural areas, with the highest cases occurring in the most remote rural areas.

  • Adults from families with incomes below 100% of the federal poverty level had a higher likelihood of having CFS/ME (2.0%) compared to those living at or above that income level (1.1%). Higher family income was associated with a lower likelihood of having the condition.

  • White non-Hispanic adults were more likely to be affected by CFS/ME, with a prevalence of 1.5%, compared to Asian non-Hispanic individuals (0.7%) and Hispanic individuals (0.8%).


In summary, chronic fatigue syndrome (CFS/ME) appears to be prevalent in the population, affecting approximately 1% to 2% of individuals regardless of factors such as age, race, gender, income, or location.

 

Chronic Fatigue Cases Higher Than Previous Estimates


In a recent survey, respondents were asked two critical questions regarding their health:

"Have you ever received a diagnosis of Chronic Fatigue Syndrome (CFS) or Myalgic Encephalomyelitis (M.E.) from a healthcare professional?"

"Do you currently experience Chronic Fatigue Syndrome (CFS) or M.E. symptoms?"


These inquiries raised concerns among experts about the accuracy of self-reported data and the reliance on respondents' memories. One notable concern was voiced by a medical professional who was not directly involved in the survey. According to this expert, the survey results may not necessarily reflect actual diagnoses of ME/CFS, as they may not have undergone comprehensive evaluations, including a thorough examination of symptoms, disability, and a review of alternative explanations for their condition.


This expert suggested that the data obtained from the survey might be better understood as a reflection of individuals reporting chronic fatigue as a symptom and the standard diagnostic labels associated with such complaints. An interesting finding from the survey was that a significant number of respondents reporting CFS/ME were in the 60 to 69 age group, which appeared surprising given that ME/ME is typically reported as most prevalent among individuals aged 40 to 60.


It is important to note that the CDC has previously reported that ME/CFS tends to be more common in people aged 40 to 60.

 

How Is Chronic Fatigue Syndrome Treated?


The treatment approach for Chronic Fatigue Syndrome (CFS) or Myalgic Encephalomyelitis (M.E.) primarily centres on symptom management and enhancing an individual's quality of life. This typically involves a comprehensive strategy that could encompass various elements. These may include using medications to address specific symptoms, implementing lifestyle modifications such as regulating activity levels and conserving energy, and providing psychological support through approaches like cognitive behavioural therapy or counselling.



Chronic Fatigue Syndrome (ME/CFS) Prevalence, Symptoms and Management FAQs

During 2021–2022, 1.3% of U.S. adults reported that a healthcare professional had diagnosed them with ME/CFS and that they still had the condition. This equates to roughly 3.3 million adults and exceeds earlier estimates of 836,000 to 2.5 million. The survey provides a nationally representative estimate based on reported current clinician diagnosis.

The higher estimate does not necessarily mean ME/CFS suddenly became more common. The CDC used a large, nationally representative household survey, while earlier studies used different populations and methods. Increased awareness and post-infectious illness following COVID-19 may also have influenced diagnosis, but the survey was not designed to identify causes or prove that long COVID produced the increase.

No. ME/CFS causes a substantial reduction in previous activity that persists for at least six months and is not adequately relieved by rest. Its defining features include post-exertional malaise and unrefreshing sleep, together with cognitive impairment or orthostatic intolerance. Ordinary tiredness usually improves with rest and does not produce the same delayed symptom crashes or sustained functional disability.

The core symptoms are disabling fatigue with reduced ability to function, post-exertional malaise and unrefreshing sleep. Diagnosis also requires cognitive impairment, often called brain fog, or orthostatic intolerance, such as dizziness or worsening symptoms while upright. Pain, headaches, sore throat and sensitivity to light, sound or temperature can also occur, but symptom patterns vary.

Post-exertional malaise is a worsening of ME/CFS symptoms after physical, mental, emotional or social activity that would previously have been manageable. The crash often begins 12–48 hours later and can intensify fatigue, pain, brain fog, sleep problems and dizziness. Recovery may take days or weeks, so pushing through symptoms can lead to repeated relapses rather than improved stamina.

Women reported ME/CFS more often than men, at 1.7% versus 0.9%. Prevalence increased with age through 60–69 years, was higher among adults with lower family incomes and rose as areas became more rural. These patterns describe reported diagnoses, not fixed biological risk, and may also reflect differences in healthcare access, recognition and diagnostic practices.

Long COVID and ME/CFS are distinct conditions with substantial overlap. Both can involve fatigue, post-exertional malaise, unrefreshing sleep, cognitive difficulties and orthostatic symptoms, and some people develop an illness meeting ME/CFS criteria after SARS-CoV-2 infection. However, not everyone with long COVID has ME/CFS, and the CDC prevalence survey did not establish how much COVID-19 affected the estimate.

Persistent fatigue should be medically assessed when it lasts for weeks, limits normal activity, does not improve with adequate rest or repeatedly worsens after minor exertion. ME/CFS is considered when the characteristic symptom pattern has continued for at least six months, but earlier evaluation is important to check for other causes, including anaemia, thyroid disorders, sleep conditions, medication effects and infections.

ME/CFS has no single cure, so management is tailored to the symptoms that most disrupt daily life. Pacing helps balance activity and rest within individual energy limits to reduce post-exertional crashes. Sleep problems, pain, cognitive difficulties and orthostatic intolerance can be addressed separately. Fixed programmes that repeatedly push activity beyond a person’s current limits can worsen symptoms and should be avoided.


Comments

Submit


Swipe up to see a Dr.

close